Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

On the herpes front.

B Grodeck

    Positively Aware : the Monthly Journal of the Test Positive Aware Network
    |January 1, 1995
    PubMed
    Summary
    This summary is machine-generated.

    Genital herpes affects 20% of the global population and is prevalent in 90% of individuals with HIV. Antiviral treatments and vaccines show promise for managing herpes transmission and improving outcomes for coinfected individuals.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    3TC receives full approval.

    Positively aware : the monthly journal of the Test Positive Aware Network·1997
    Same author

    Nelfinavir (Viracept) moves up the ranks.

    Positively aware : the monthly journal of the Test Positive Aware Network·1997
    Same author

    Marijuana as medicine?

    Positively aware : the monthly journal of the Test Positive Aware Network·1997
    Same author

    Is immune boosting the next step?

    Positively aware : the monthly journal of the Test Positive Aware Network·1997
    Same author

    The kissing question and other ICAAC highlights.

    Positively aware : the monthly journal of the Test Positive Aware Network·1996
    Same author

    A, B, C, D, E...any school child can tell you not to mess with viral hepatitis.

    Positively aware : the monthly journal of the Test Positive Aware Network·1995

    Area of Science:

    • Virology
    • Epidemiology
    • Public Health

    Background:

    • Genital herpes, caused by herpes simplex virus (HSV), is highly prevalent globally, affecting 20% of the population.
    • Coinfection with Human Immunodeficiency Virus (HIV) significantly increases HSV incidence, reaching up to 90% in some populations.
    • Herpes viruses are considered cofactors that can promote HIV infection.

    Discussion:

    • A significant portion of herpes cases remain unrecognized, with only 20% of seropositive individuals recognizing their symptoms.
    • Unrecognized symptomatic disease accounts for 60% of cases, while 20% involve subclinical, asymptomatic viral shedding.
    • This high rate of unrecognized and asymptomatic shedding contributes to the ongoing transmission of genital herpes.

    Key Insights:

    • Acyclovir demonstrates potential in reducing herpes transmission.

    Related Experiment Videos

  • Individuals with herpes should practice abstinence during outbreaks and use barrier protection at other times.
  • Combination therapy with Acyclovir and AZT offers survival benefits for individuals with AIDS.

    • Outlook:

    • Newer antiviral generations may offer improved efficacy for herpes treatment.
    • Post-infection vaccines for herpes are under development and represent a promising future strategy.
    • Effective management of genital herpes is crucial for public health, particularly in populations coinfected with HIV.